pneumococcal conjugate vaccines
The Future of Pneumococcal Conjugate Vaccines for Prevention of Pneumococcal Diseases in Infants and Children
... Seven-valent pneumococcal conjugate vaccine (PCV7) was licensed in February ...of pneumococcal conjugate vaccine for all children 23 months of age and younger and for children 24 to 59 months ...
12
Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case–control study
... 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13), changes in pneumococcal upper airway colonization have been ...the vaccines lead to compositional changes of the upper airway ...
14
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
... 19F-containing pneumococcal conjugate vaccines can provide some direct protection against 19A ...certain vaccines with different conjugation methods and carrier proteins have shown ...
7
Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction based surveillance: an experience from South Africa
... 1 Enrolment of cases with severe acute respiratory illness SARI program and cases of culture-positive invasive pneumococcal disease GERMS program hospitalized at Chris Hani-Baragwanath A[r] ...
13
Cost effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
... of pneumococcal vaccines against clinical AOM between the POET [7] and FinOM [35] ...(11-valent pneumococcal polysaccharide conjugate vaccine conju- gated to ...
12
Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis
... invasive pneumococcal diseases (IPDs, ...Before pneumococcal conjugate vaccine (PCV) introduction, the incidence of these IPDs in children aged under 2 years was ...of pneumococcal menin- ...
11
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
... invasive pneumococcal disease (IPD), pneumonia, and acute otitis media (AOM) [1-3], has prompted policy- makers to ponder whether or not this vaccine should be included in the national immunization ...PCV ...
12
Cost effectiveness of 2 + 1 dosing of 13 valent and 10 valent pneumococcal conjugate vaccines in Canada
... In this analysis, we considered both direct effects and a combination of direct and indirect effects of the vac- cines. However, evidence of indirect effects for PCV10 and PCV13 are limited in the literature. Indirect ...
13
Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
... 111 Systematic reviews that have been done so far on the impact of PCV in Africa have 112 focused on carriage and clinical pneumonia endpoints in children. 17,18 None have 113 summarised these data in the adult or ...
20
Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis
... of pneumococcal conjugate vac- cines are needed, including studies of the optimal dosage schedules for safety and efficacy for the ad- ministration of PCV7 and 23PS vaccine for healthy and high-risk ...
12
Cost effectiveness analysis of pneumococcal conjugate vaccine 13 valent in older adults in Colombia
... a pneumococcal vaccine with a different tech- nology was launched, which conjugates pneumococcal serotypes with a diphtheria protein ...the pneumococcal conjugate vaccine 7-valent (PCV7) that ...
9
Cloning of Minor Autolysin of Streptococcus Pneumoniae
... mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus ...protein vaccines to protect against otitis media caused by Streptococcus ...
7
Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE
... institutional EHRs will reduce this time burden in the future. However, primary care providers are not required to enter vaccine history into the statewide database, and it does not include vaccines that were ...
11
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
... to pneumococcal polysaccharides may be the only detectable immune abnormality or it may be as- sociated with IgG2 subclass deficiency or other B-cell dis- turbances [26, ...
7
Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
... (Hib) vaccine and oral polio vaccine; see Table 1) were administered by the study HEOs/nurses at 1, 2, and 3 months of age, together with the 10vPCV or 13vPCV study vaccines. Information on birth doses of Bacillus ...
15
Age-Specific Immunoglobulin G (IgG) and IgA to Pneumococcal Protein Antigens in a Population in Coastal Kenya
... As human immunodeficiency virus (HIV)-infected persons have impaired responses to at least one pneumococcal protein antigen (1), the age-specific pattern of antibody concentration may have been confounded by HIV ...
6
Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore
... new vaccines for prevention of pneumonia in adults, vaccine uptake rates need to be improved significantly to tackle adult pneumococcal disease ...regarding pneumococcal disease and improved vaccine ...
13
Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam
... Genetic analysis of tetracycline resistance genes tet(M) and tet(O) revealed the tet(M) gene in 91% of the Vietnamese isolates. This is in line with observations made by Luna and Roberts (24), who have demonstrated the ...
6
Recurrent severe invasive pneumococcal disease in an adult with previously unknown hyposplenia
... Table 2 Recommended immunizations against invasive pneumococcal disease using the 13-valent pneumococcal conjugate vaccine PCV13 and the 23-valent pneumococcal polysaccharide vaccine PPV[r] ...
7